Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-Blockers for Dysuria After HoLEP
NCT06865430Recruiting
- Sponsor
- Ankara Training and Research Hospital
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Ankara Training and Research Hospital. Primary endpoints: Dysuria Visual Analog Scale at 1 month, Urgency Visual Analog Scale at 1 month and 1 more. Started Mar 2025; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06865430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865430.